AUSTIN, Texas , Dec. 6, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the fourth quarter of 2019 of $0.09 per share of common stock payable on January 15 , 2019 to stockholders of record as of the
AUSTIN, Texas , Nov. 25, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Harriss Currie , Senior Vice President of Finance and CFO, will participate in investor meetings and present at the Piper Jaffray 31 st Annual Healthcare Conference on Wednesday, December 4, 2019
AUSTIN, Texas , Nov. 4, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2019 . All amounts in this release are in conformity with U.S. generally accepted accounting principles ("GAAP").
AUSTIN, Texas , Oct. 25, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the third quarter ended September 30, 2019 on Monday, November 4, 2019 after the market close. The company will host a conference call that day at 5:00 p.m.
AUSTIN, Texas , Oct. 1, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced that the company has received U.S. Food and Drug Administration ( FDA ) 510(k) clearance for the ARIES ® MRSA Assay. The assay is an integrated, real-time, polymerase chain reaction (PCR) based, qualitative,
AUSTIN, Texas , Sept. 26, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir , President and Chief Executive Officer, and Harriss Currie , Senior Vice President of Finance and CFO, will participate in investor meetings and present at the Cantor Global
AUSTIN, Texas , Sept. 3, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir , President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Morgan Stanley 17th Annual Global Healthcare Conference to be held September 9-11, 2019
AUSTIN, Texas , July 31, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced financial results for the second quarter 2019. Financial and operating highlights for the quarter include: Second quarter consolidated revenue increased 4% to $83.1 million from $79.6 million in the
AUSTIN, Texas , July 11, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the second quarter ended June 30, 2019 on Wednesday, July 31, 2019 . A press release announcing the results is scheduled for release after the close of trading on
AUSTIN, Texas , July 1, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced that the company submitted the ARIES® MRSA Assay to the U.S. Food and Drug Administration ( FDA ) for clearance on Friday, June 28, 2019 . The assay is a real-time, quantitative polymerase chain reaction
